Category: Regulatory & Safety

Outsourcing from a Pharmacovigilance Perspective

The Do’s and Don’ts of Randomization in Clinical Trials

Balancing Scientific Value and Identification Risk in Anonymization

Eligibility Criteria in Clinical Trials

The Future of The Local Regulatory Affiliate: Adjusting To Global Strategies, Processes and Expectations

Positive Changes in the Latin American Clinical Trial Regulatory Environment

Seeking Ways to Ensure Participant Safety in First-in-Human Trials

Brexit’s Potential Regulatory Impact on the Pharmaceutical Industry

Major Clinical Trial Reforms Underway in China’s Regulatory Environment